Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
412,914,375
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
2,531,115
-
Shares change
-
-358,643
-
Total reported value, excl. options
-
$3,327,272
-
Value change
-
-$562,185
-
Number of buys
-
1
-
Number of sells
-
6
-
Price
-
$1.32
Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q2 2023
As of 30 Jun 2023 Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,531,115 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Ikarian Capital, LLC, KESTRA PRIVATE WEALTH SERVICES, LLC, BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, RHUMBLINE ADVISERS, OSAIC HOLDINGS, INC., Newbridge Financial Services Group, Inc., MORGAN STANLEY, and UBS Group AG.
This table shows 10 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.